10X Capital β Full Portfolio
7 tracked investments Β· listed companies and verified rows first
Maximus is an online telehealth clinic offering clinically-validated, personalized prescription protocols and lab testing focused on health optimization ("performance medicine") for men and women, covering areas like testosterone optimization, medical weight loss, hair regrowth, and stress/sleep support.
Digital HealthHealthtechLongevityWellness & FitnessLos Angeles, US
S. Cameron Sepah(Founder & CEO)Cameron Sepah(Founder)in
Co-investors8VCFounders FundAbstract VenturesCarnrite VenturesChamaeleonCorrelation Ventures+6 more
10X is a company focused on transforming the retail industry, particularly supermarkets, through product innovation.
AI & Machine LearningE-commerceRetail Tech
η’ζ¬ (Yamoto)
Co-investorsGlobal BrainGMO VenturePartnersKDDI Open Innovation FundNOW JapanFounders Fund
Camino Financial, based in Los Angeles, operates an online lending platform that also makes its technology available as a service.
Los Angeles, US
Kenneth Salas(Executive Officer, Director)inSean Salas(Founder)inSean Sakas(Executive Officer, Director)
Co-investorsDila CapitalImpact America FundRadicle ImpactCollaborative Fund
Identifee provides a platform that unifies fragmented core data, CRM, and BI systems into one connected system for banks and credit unions to use without training.
AI & Machine LearningData & InfrastructureFintechSaaSCovina, US
Vram Ismailyan(CEO and Co-Founder)inVigen Ismailyan(Executive Officer, Director)Kevin Miyamoto(Executive Officer, Director)Joseph Proto(Director)
BoardDavid Zinn(Director)in
Co-investorsAltari VenturesOcean Azul Partners
Tactogen develops patented new chemical entities, including benzofuran-based compositions, and conducts preclinical research and publishes data on these compounds.
BiotechDeep TechHealthtech
Matthew Baggott(CEO)in
Co-investorsLeafy TunnelNoeticPsyMed VenturesPalo SantoWefunder
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.